|
COSTA MESA, California - March 1, 2000 - IOP, Inc.,
the premier developer and distributor of specialty devices
for surgery, announced the introduction of the BioSpacer™
Tutoplast® Sclera for the treatment of lower eyelid retraction.
This configuration-addition to the Company's Tutoplast®
line is yet another tissue processed specifically for the
ophthalmic plastic and reconstructive surgical market.
Processed human tissues have been used by ophthalmologist
for a variety of procedures. In the treatment of lower eyelid
retraction, surgeons routinely insert a tissue substrate (like
sclera) into the lower eye to provide tectonic support and
lift. Tutoplast® represents the gold standard worldwide
for human tissue processing.
"Once again, we are trying to respond to the needs of our
customers…. the oculoplastic surgeons worldwide," responded
Erich Ziegler, Director of New Product Development. "We are
extremely proud of our ongoing efforts in providing surgeons
with safe and effective tissue grafts for surgery. The market
response has been extremely positive."
During the past 30 years, over 750,000 Tutoplast®
Processed Allografts have been surgically transplanted without
a single documented case of disease transmission.
IOP, Inc. is committed to improving the quality of life of
people worldwide ….to elevating surgical performance through
ideas, innovation and technology.
Media Contact:
media@iopinc.com
Back to Archives
|
